Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Kaye LeMoine"'
Autor:
Aneal Khan, Dwayne L. Barber, Ju Huang, C. Anthony Rupar, Jack W. Rip, Christiane Auray-Blais, Michel Boutin, Pamela O’Hoski, Kristy Gargulak, William M. McKillop, Graeme Fraser, Syed Wasim, Kaye LeMoine, Shelly Jelinski, Ahsan Chaudhry, Nicole Prokopishyn, Chantal F. Morel, Stephen Couban, Peter R. Duggan, Daniel H. Fowler, Armand Keating, Michael L. West, Ronan Foley, Jeffrey A. Medin
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-9 (2021)
Treatments for Fabry disease, an inherited lysosomal disorder caused by the deficiency of the enzyme alpha-galactosidase A, are not fully efficacious. Here the authors report a single-arm phase I trial of gene therapy with autologous, lentivirus-tran
Externí odkaz:
https://doaj.org/article/e1df374ec9104eca99e1b0892655fcfa
Autor:
Aizeddin A. Mhanni, Christiane Auray-Blais, Michel Boutin, Alie Johnston, Kaye LeMoine, Jill Patterson, Johannes M.F.G. Aerts, Michael L. West, Cheryl Rockman-Greenberg
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 24, Iss , Pp 100618- (2020)
Enzyme replacement therapy (ERT) has been shown to stabilize certain aspects of Fabry disease (FD). However, in some patients on ERT, high antibody titres have been documented, with limited clinical improvement in systemic manifestations and often wi
Externí odkaz:
https://doaj.org/article/23d63e924b9b4c13a433ac1a3d2aa15a
Autor:
Jill Patterson, Kaye LeMoine, Alie J. Johnston, Christiane Auray-Blais, Michael West, Cheryl Rockman-Greenberg, Johannes M. F. G. Aerts, Michel Boutin, Aizeddin A. Mhanni
Publikováno v:
Molecular Genetics and Metabolism Reports
Molecular Genetics and Metabolism Reports, Vol 24, Iss, Pp 100618-(2020)
Molecular Genetics and Metabolism Reports, 24, 100618. ELSEVIER
Molecular Genetics and Metabolism Reports, Vol 24, Iss, Pp 100618-(2020)
Molecular Genetics and Metabolism Reports, 24, 100618. ELSEVIER
Enzyme replacement therapy (ERT) has been shown to stabilize certain aspects of Fabry disease (FD). However, in some patients on ERT, high antibody titres have been documented, with limited clinical improvement in systemic manifestations and often wi
Autor:
Kaye LeMoine, Syed Wasim, Marie-Françoise Arthus, Michael West, Robin H. Lachmann, Larry D. Lynd, Daniel G. Bichet, Cheryl Rockman-Greenberg, Sandra Sirrs, Carla E. M. Hollak, Chantal F. Morel
Publikováno v:
Value in health, 24(2), 268-273. Elsevier Limited
Objectives Orphan medicinal products (OMPs) often receive market authorization under conditions imposed by regulators for ongoing postauthorization surveillance (PAS) to answer questions that remain at the time of market entry. This surveillance may
Autor:
Aneal Khan, Christiane Auray-Blais, Mark R. Iwanochko, Daniel G. Bichet, Michael West, Kaye LeMoine, Sandra Sirrs
Publikováno v:
Molecular Genetics and Metabolism. 132:S111
Autor:
Mark R. Iwanochko, Daniel G. Bichet, Kaye LeMoine, Sandra Sirrs, Christiane Auray-Blais, Michael West, Aneal Khan
Publikováno v:
Molecular Genetics and Metabolism. 132:S111
Autor:
Christiane Auray-Blais, Joe T.R. Clarke, Robin Casey, Gordon Flowerdew, Sandra Sirrs, Michael West, Kaye LeMoine, Daniel G. Bichet
Publikováno v:
Scopus-Elsevier
Autor:
Michael West, Sandra Sirrs, Daniel G. Bichet, Robin Casey, Gordon Flowerdew, J.T.R. Clarke, Kaye LeMoine, David S. Sinasac
Publikováno v:
Molecular genetics and metabolism. 99(4)
The Canadian Fabry Disease Initiative [CFDI] is a longitudinal study evaluating all Canadians diagnosed with Fabry disease [FD]. The study has 3 cohorts: Cohort 1A which includes 81 subjects who were on enzyme replacement therapy [ERT] prior to Octob
Autor:
Michael West, Kaye LeMoine
Publikováno v:
Molecular Genetics and Metabolism.
Autor:
Christiane Auray-Blais, Michael West, Robin Casey, Kaye LeMoine, Joe T.R. Clarke, Johannes M. F. G. Aerts, Sandra Sirrs, Daniel G. Bichet
Publikováno v:
Molecular Genetics and Metabolism. 108:S97-S98